Search research articles
Contact Us
Filters
Showing results (81-90 of 88) with videos related to
Page
of 9
Sort By:
You have reached the last page of results.
This site can display upto 88 results.
Leukemia
|
April 26, 2017
Efficacy and safety of carfilzomib regimens in multiple myeloma patients relapsing after autologous stem cell transplant: ASPIRE and ENDEAVOR outcomes
P Hari, M-V Mateos, R Abonour, et al.
Leukemia
|
May 29, 2010
Bortezomib, dexamethasone, cyclophosphamide and lenalidomide combination for newly diagnosed multiple myeloma: phase 1 results from the multicenter EVOLUTION study
S K Kumar, I Flinn, S J Noga, et al.
Bone Marrow Transplantation
|
July 19, 2016
A multicenter trial of myeloablative clofarabine and busulfan conditioning for relapsed or primary induction failure AML not in remission at the time of allogeneic hematopoietic stem cell transplantation
J Magenau, P Westervelt, S Khaled, et al.
Leukemia
|
December 22, 2017
Early relapse after autologous hematopoietic cell transplantation remains a poor prognostic factor in multiple myeloma but outcomes have improved over time
S K Kumar, A Dispenzieri, R Fraser, et al.
Leukemia
|
November 2, 2011
Hematopoietic cell transplantation for primary plasma cell leukemia: results from the Center for International Blood and Marrow Transplant Research
A Mahindra, M E Kalaycio, J Vela-Ojeda, et al.
Bone Marrow Transplantation
|
September 19, 2017
Autologous hematopoietic cell transplantation for multiple myeloma patients with renal insufficiency: a center for international blood and marrow transplant research analysis
A Mahindra, P Hari, R Fraser, et al.
Hematology/Oncology and Stem Cell Therapy
|
August 27, 2019
Worldwide Network for Blood and Marrow Transplantation (WBMT) recommendations for establishing a hematopoietic stem cell transplantation program in countries with limited resources (Part II): Clinical, technical and socio-economic considerations
M Aljurf, D Weisdorf, S K Hashmi, et al.
Leukemia
|
June 17, 2017
Natural history of relapsed myeloma, refractory to immunomodulatory drugs and proteasome inhibitors: a multicenter IMWG study
S K Kumar, M A Dimopoulos, E Kastritis, et al.
Page
of 9
Search research articles
Search
Showing results (81-90 of 88) with videos related to
Sort By:
Page
of 9
You have reached the last page of results.
This site can display upto 88 results.
Leukemia
|
April 26, 2017
Efficacy and safety of carfilzomib regimens in multiple myeloma patients relapsing after autologous stem cell transplant: ASPIRE and ENDEAVOR outcomes
P Hari, M-V Mateos, R Abonour, et al.
Leukemia
|
May 29, 2010
Bortezomib, dexamethasone, cyclophosphamide and lenalidomide combination for newly diagnosed multiple myeloma: phase 1 results from the multicenter EVOLUTION study
S K Kumar, I Flinn, S J Noga, et al.
Bone Marrow Transplantation
|
July 19, 2016
A multicenter trial of myeloablative clofarabine and busulfan conditioning for relapsed or primary induction failure AML not in remission at the time of allogeneic hematopoietic stem cell transplantation
J Magenau, P Westervelt, S Khaled, et al.
Leukemia
|
December 22, 2017
Early relapse after autologous hematopoietic cell transplantation remains a poor prognostic factor in multiple myeloma but outcomes have improved over time
S K Kumar, A Dispenzieri, R Fraser, et al.
Leukemia
|
November 2, 2011
Hematopoietic cell transplantation for primary plasma cell leukemia: results from the Center for International Blood and Marrow Transplant Research
A Mahindra, M E Kalaycio, J Vela-Ojeda, et al.
Bone Marrow Transplantation
|
September 19, 2017
Autologous hematopoietic cell transplantation for multiple myeloma patients with renal insufficiency: a center for international blood and marrow transplant research analysis
A Mahindra, P Hari, R Fraser, et al.
Hematology/Oncology and Stem Cell Therapy
|
August 27, 2019
Worldwide Network for Blood and Marrow Transplantation (WBMT) recommendations for establishing a hematopoietic stem cell transplantation program in countries with limited resources (Part II): Clinical, technical and socio-economic considerations
M Aljurf, D Weisdorf, S K Hashmi, et al.
Leukemia
|
June 17, 2017
Natural history of relapsed myeloma, refractory to immunomodulatory drugs and proteasome inhibitors: a multicenter IMWG study
S K Kumar, M A Dimopoulos, E Kastritis, et al.
Page
of 9